Eric Ehlenberger
Emergency Medicine · Kenner, LANPI 1518073576
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,485 of the $9,665 with a category attached, or 77.4%. 35 manufacturers reported payments, led by Biodelivery Sciences International, Inc. at 27.5% of the total. Reporting peaked in 2019 at $3,368 and has fallen 55.2% since, to $1,510 in 2025. Among emergency medicine clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 434 payments — averaging $22.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biodelivery Sciences International, Inc.$3K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$869
- AbbVie$711
- Scilex Pharmaceuticals Inc.$638
- Collegium Pharmaceutical, Inc.$626
- Pfizer$577
- plus $4K from 29 others
What the payments were for
- Speaking & faculty fees$2,00021%
- Travel & lodging$1802%
- Food & beverage$7,48577%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biodelivery Sciences International, Inc. | 18 | $2,659 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 76 | $869 |
| AbbVie | 37 | $711 |
| Scilex Pharmaceuticals Inc. | 46 | $638 |
| Collegium Pharmaceutical, Inc. | 46 | $626 |
| Pfizer | 30 | $577 |
| Biohaven Pharmaceutical Holding Company Ltd. | 27 | $488 |
| Biohaven Pharmaceuticals, Inc. | 20 | $464 |
| Valinor Pharma, LLC | 35 | $437 |
| Forte Bio-pharma LLC | 6 | $382 |
| Virtus Pharmaceuticals LLC | 11 | $262 |
| Sentynl Therapeutics, Inc. | 22 | $214 |
| Indivior Inc. | 6 | $192 |
| Protega Pharmaceutials Inc | 1 | $181 |
| Idorsia Pharmaceuticals US Inc | 5 | $173 |
| Averitas Pharma Inc. | 4 | $113 |
| Vertex | 3 | $112 |
| Zyla Life Sciences, Inc. | 19 | $110 |
| Tonix Medicines, Inc. | 1 | $84 |
| Kaleo, Inc. | 4 | $65 |
| Axsome Therapeutics, Inc. | 3 | $65 |
| Appliedvr Inc | 1 | $31 |
| IBSA Pharma Inc. | 1 | $25 |
| Impel Pharmaceuticals Inc. | 1 | $23 |
| Amgen | 1 | $21 |
| GRT US Holding, Inc. | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $18 |
| Shionogi Inc | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| MDD US Operations, LLC | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $11 |
| Impel Pharmaceuticals LLC | 1 | $7 |
| Assertio Therapeutics, Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,665 in reported general payments places this provider in the 95th percentile of 881 emergency medicine providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 638 | $466,063 |
| BelbucaBuprenorphine Hcl | 159 | $147,679 |
| ZtlidoLidocaine | 143 | $144,998 |
| Lidocan IiiLidocaine | 53 | $125,870 |
| Levorphanol Tartrate | 49 | $87,137 |
| RelistorMethylnaltrexone Bromide | 35 | $80,404 |
| Xtampza ErOxycodone Myristate | 71 | $65,746 |
| Lidocaine | 194 | $41,847 |
| Nurtec OdtRimegepant Sulfate | 19 | $38,433 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 761 | $36,952 |
| Nucynta ErTapentadol Hcl | 47 | $36,840 |
| OxycontinOxycodone Hcl | 35 | $34,127 |
| NucyntaTapentadol Hcl | 12 | $30,945 |
| QuviviqDaridorexant Hcl | 60 | $29,441 |
| QuliptaAtogepant | 25 | $29,244 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er, Nucynta Er, Nucynta | $626 | $281,211289 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $638 | $144,998143 claims |
| Virtus Pharmaceuticals LLCLevorphanol Tartrate | $262 | $87,13749 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $869 | $80,40435 claims |
| PfizerNurtec Odt | $577 | $38,43319 claims |
| Idorsia Pharmaceuticals US IncQuviviq | $173 | $29,44160 claims |
| AbbVieQulipta | $711 | $29,24425 claims |
| Redhill Biopharma Inc.Movantik | $18 | $19,22048 claims |
| Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate | $18 | $14,42680 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 881 emergency medicine providers in Louisiana.
Other emergency medicine in Kenner
- Fred WillisShreveport$427K
- Bryant BoydShreveport$83K
- Thomas ArnoldShreveport$48K
- Noah PoresNew Orleans$34K
- Granville MorseNew Orleans$32K
- Claude DantonioNew Orleans$26K
- Guy LefortCut Off$24K
- Mark DemanuelleDonaldsonville$22K
- Mace ScottBogalusa$17K
- Lisa FortNew Orleans$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.